UniProtKB/Swiss-Prot P28329: Variant p.Ile305Thr

Choline O-acetyltransferase
Gene: CHAT
Chromosomal location: 10q11.2
Variant information

Variant position:  305
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Disease [Disclaimer]
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants have been found in patients and disease-association is reported in literature. However, this classification is not a definitive assessment of variant pathogenicity.
  • Polymorphism: No disease-association has been reported.
  • Unclassified: Variants have been found in patients but disease-association remains unclear.

Residue change:  From Isoleucine (I) to Threonine (T) at position 305 (I305T, p.Ile305Thr).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and hydrophobic (I) to medium size and polar (T)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In CMSEA; impaired activity.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  305
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  748
The length of the canonical sequence.

Location on the sequence:   HTQDTLVAQNSSIMPEPEHV  I VACCNQFFVLDVVINFRRLS
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         HTQDTLV-AQNSSIMPEPEHVIVACCNQFFVLDVVINFR-RLS

Mouse                         HTQDTLV-AQKSSIMPEPEHVIVACCNQFFVLDVVINFR-R

Rat                           HTQDTLV-AQKSSIMPEPEHVIVACCNQFFVLDVVINFR-R

Pig                           HTQDTLV-AQKSSVMPEPEHVIVACCNQFFVLDVVINFR-R

Chicken                       HTKDTLV-AQKSCVMPEPEHIIVACNNQLFVLDVGINFR-R

Zebrafish                     TKTDTLV-AQKSTVMPEPEHIIVACKNQFFVLDVMVNFR-R

Caenorhabditis elegans        VGEDTQI--RKQKTNDGNEHVLVMCRNQTFLLHSRINGA-L

Drosophila                    VKQDSQFLPSRERLNDEDRHVVVICRNQMYCVVLQASDRGK

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 748 Choline O-acetyltransferase
Beta strand 300 – 308


Literature citations

Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans.
Ohno K.; Tsujino A.; Brengman J.M.; Harper C.M.; Bajzer Z.; Udd B.; Beyring R.; Robb S.; Kirkham F.J.; Engel A.G.;
Proc. Natl. Acad. Sci. U.S.A. 98:2017-2022(2001)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS M; R AND S); ALTERNATIVE SPLICING; VARIANTS CMSEA PRO-210; ALA-211; THR-305; CYS-420; LYS-441; GLY-482; LEU-498; LEU-506 AND HIS-560; VARIANTS THR-120; GLY-392 AND MET-461;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.